Meiwu's 1-for-100 Split: A Bid to Survive on Nasdaq

SHENZHEN, China – April 01, 2026 – Meiwu Technology Company Limited is undertaking one of the most aggressive financial maneuvers available to a publicly traded company, announcing a 1-for-100 reverse share split set to take effect on April 6. The move, which will consolidate every 100 of its ordinary shares into a single share, is a dramatic attempt to rescue its stock price from deep sub-dollar territory and maintain its precarious listing on the Nasdaq Capital Market.

For investors, this action reduces the number of outstanding shares from over 133 million to approximately 1.33 million. While the company's ticker symbol, WNW, will remain the same, the stock's character and the stakes for its survival have been fundamentally altered. The critical question facing the market is whether this is a strategic reset for a company pivoting into the lucrative skincare industry or simply the latest chapter in a prolonged battle against delisting.

A Familiar Fight for Compliance

This is not Meiwu Technology's first encounter with Nasdaq's compliance officers. The exchange mandates that listed companies maintain a minimum bid price of $1.00 per share. Falling below this threshold for 30 consecutive business days triggers a deficiency notice and starts a countdown clock to regain compliance or face delisting.

Meiwu has been living on this clock. Almost exactly one year ago, in March 2025, the company faced a delisting notice after its shares languished below the minimum requirement. Its solution then was a 1-for-20 reverse stock split, which took effect on April 1, 2025. For a brief period, the strategy worked. By late April 2025, the stock had climbed above $1.00 for ten consecutive days, satisfying Nasdaq's rule and pulling the company back from the brink.

The relief was short-lived. The artificially inflated price could not hold, and the stock began a relentless slide. Despite the previous split, Meiwu's shares have plummeted over 97% in the last year, recently closing at a low of $0.0770 on March 30, 2026. This collapse rendered the previous split a temporary fix and forced the board's hand once again, leading to the far more drastic 1-for-100 consolidation approved on March 17. This pattern of repeated, and increasingly severe, reverse splits is often viewed by regulators and analysts as a hallmark of a company in "deep financial or operational distress."

Market Skepticism and Shareholder Impact

While the 1-for-100 split will mathematically lift Meiwu's share price—from around $0.10 to a theoretical $10.00—it does not create any new value for the company. Market capitalization remains unchanged. The company itself acknowledged this uncertainty in its official announcement, cautioning that it "cannot assure that the price of its Ordinary Shares after the reverse split will reflect the 1-for-100 reverse split ratio... or that the price will remain above the pre-split trading price."

This warning is well-founded. The market's reaction to such measures is often deeply skeptical. While the stock saw a brief pre-split bump on the day of the announcement, the broader sentiment remains bearish. Analyst coverage is sparse and negative, with MarketBeat reporting a consensus "Sell" rating. Furthermore, institutional ownership is a minuscule 0.14%, signaling a profound lack of confidence from large, sophisticated investors who typically avoid highly volatile and financially stressed penny stocks.

For existing shareholders, the immediate impact is a drastic reduction in the number of shares they hold, with fractional shares being rounded up. The hope is for a higher, more stable price per share. However, history shows that stocks undergoing high-ratio reverse splits often attract short-sellers and can experience significant downward pressure as the market continues to question the company's fundamental health.

A Pivot into the Competitive World of Skincare

The financial engineering on display is a backdrop to a larger, more ambitious transformation Meiwu is attempting to navigate. Originally an online vendor of food products and SMS services, the company has strategically shifted its focus to the booming functional skincare market in China through its subsidiary, Xiamen Chunshang Health Technology Co., Ltd.

This pivot places Meiwu in one of the world's most dynamic but fiercely competitive consumer markets. The Chinese beauty and personal care industry is projected to be worth $78 billion by 2025. It is a landscape defined by rapid innovation, with trends like "science fetishism"—a consumer obsession with potent, scientifically-backed ingredients like peptides and retinol—and the integration of AI-driven personalization. At the same time, local Chinese brands are rapidly gaining market share by leveraging their deep understanding of consumer preferences and nimble supply chains.

Meiwu's financial reports paint a picture of a company in transitionary turmoil. Its three-year revenue growth rate is a staggering -90.5%. While the company recently raised approximately $14 million in a registered direct offering to shore up its balance sheet, its Altman Z-Score of 2.25 places it in a "grey area" of financial distress. The reverse split, in this context, can be seen as an essential move to clean up its capital structure and maintain a Nasdaq listing, which can be crucial for attracting future investment needed to fund its skincare ambitions. The company has signaled its intent to compete on technology, announcing a "Strategic AI Insights Initiative" in March to support product innovation. However, whether it can successfully execute this strategy and carve out a profitable niche against established domestic and international players remains a significant uncertainty. The success of this pivot, not financial maneuvers, will ultimately determine the company's long-term fate.